Literature DB >> 25489326

A new strategy to identify potentially dangerous coronary arterial patterns before percutaneous pulmonary valve implantation.

Sebastian Góreczny1, Andreas Eicken2, Peter Ewert2, Gareth John Morgan3, Sohrab Fratz2.   

Abstract

Despite advances in surgical techniques, right ventricular outflow tract (RVOT) conduits are prone to fail over time. Percutaneous pulmonary valve implantation was introduced to expand the lifetime of these conduits and to decrease the number of open heart operations during a patient's lifetime. The procedure can be performed with excellent results; however, serious complications such as coronary arterial compression and conduit rupture have been reported. We present percutaneous treatment of a patient after Ross-Konno operation with RVOT conduit dysfunction and a potentially problematic course of the left anterior descending artery.

Entities:  

Keywords:  coronary compression; percutaneous pulmonary valve implantation

Year:  2014        PMID: 25489326      PMCID: PMC4252329          DOI: 10.5114/pwki.2014.46773

Source DB:  PubMed          Journal:  Postepy Kardiol Interwencyjnej        ISSN: 1734-9338            Impact factor:   1.426


Introduction

Despite advances in surgical techniques, right ventricular outflow tract (RVOT) conduits are prone to fail over time [1]. Patients with surgically reconstructed outflow tracts often require multiple open heart operations during their lifetime. Percutaneous pulmonary valve implantation (PPVI) was introduced to decrease the number of open heart operations and increase the lifespan of conduits by removing obstruction and revalving the surgically placed outflow tube [2]. This procedure can be performed with excellent short- and mid-term results, with low morbidity and mortality [3-5]. One of the most serious potential complications is coronary arterial compression [6, 7]. Preprocedural imaging (computed tomography (CT) or cardiovascular magnetic resonance (CMR)), careful patient selection, and a patient-modified approach during the procedure can guide a safe and successful intervention [4]. The large variation in anatomy that exists amongst patients who require RVOT conduits leads to significant diversity in the relationship between the outflow anatomy and the coronary arterial course [8]. Coronary arterial compression, a potentially fatal complication, may occur during PPVI [3, 4, 6, 9]. To minimise the risk of this major adverse event we suggest noninvasive imaging followed by meticulous biplane visualisation of the coronary anatomy. Introduction of a coronary guide wire to the segment of the artery deemed to be a hazard during RVOT conduit expansion may provide further information regarding the risk of coronary compression. We present the findings of a patient after Ross-Konno operation with dysfunction of the RVOT conduit. In CMR a potentially dangerous course of the left anterior descending (LAD) artery was noticed. The balloon test was done with concomitant placement of a coronary guidewire to exclude a compression of the LAD during PPVI.

Case report

A 15-year-old boy (177 cm, 97 kg) presented with mixed stenotic and regurgitant dysfunction of an RVOT conduit. Following an initial neonatal aortic balloon valvuloplasty a Ross-Konno operation was performed in infancy. Five years later the initial RVOT conduit (pulmonary homograft) was replaced with a 20 mm bovine xenograft conduit (Contegra, Medtronic Inc, Minneapolis, MN). The patient presented in good clinical condition with typical ECG and echocardiographic findings of RVOT conduit dysfunction. The maximal RVOT velocity (Vmax, continuous wave Doppler) was 4.2 m/s, with proximal stenosis of the conduit and significant pulmonary regurgitation. Cardiovascular magnetic resonance demonstrated good global biventricular function without regional wall disturbances and moderate right ventricular hypertrophy. The RV was mildly dilated with an indexed end diastolic volume of 88 ml/m2. The coronary artery origins were in the usual positions. The right coronary artery was far from the conduit, whereas the LAD branch coursed parallel to and postero-inferior to the conduit at a distance of approximately 4 mm (Figures 1A–D). This arrangement was deemed to be potentially high risk for coronary compression therefore further interrogation was performed.
Figure 1

ECG-triggered and respiratory navigator-gated 3D balanced Steady-State Free Precision CMR images. A – Para-axial plane on the level of main pulmonary artery bifurcation, B – plane slightly caudal on the level of left coronary artery origin and the proximal segment of the LAD (white arrows) branch, C – para-sagittal and D – coronal planes. The LAD branch courses directly beneath and parallel to the narrow conduit (white stars) creating potential conflict in case of expansion of the conduit

CMR – cardiovascular magnetic resonance, LAD – left anterior descending, AO – ascending aorta, LPA – left pulmonary artery, RPA – right pulmonary artery, RV – right ventricle, RA – right atrium, LV – left ventricle

ECG-triggered and respiratory navigator-gated 3D balanced Steady-State Free Precision CMR images. A – Para-axial plane on the level of main pulmonary artery bifurcation, B – plane slightly caudal on the level of left coronary artery origin and the proximal segment of the LAD (white arrows) branch, C – para-sagittal and D – coronal planes. The LAD branch courses directly beneath and parallel to the narrow conduit (white stars) creating potential conflict in case of expansion of the conduit CMR – cardiovascular magnetic resonance, LAD – left anterior descending, AO – ascending aorta, LPA – left pulmonary artery, RPA – right pulmonary artery, RV – right ventricle, RA – right atrium, LV – left ventricle At cardiac catheterisation under general anaesthesia, angiography delineated a tight proximal stenosis of the conduit with a minimal diameter of 11 mm. Moderate calcifications around the proximal segment of the conduit were noted (Figures 2A, B). Haemodynamic measurements were performed (right ventricle – 52/5/13 mm Hg, pulmonary artery – 23/12/15 mm Hg, aorta – 85/62/79 mm Hg). For balloon testing an 18 mm low-pressure balloon (BiB, NuMed Inc, Hopkinton, NY) was inflated in the RVOT with concomitant selective left coronary angiography in posterior-anterior and left lateral projections. As depicted by CMR, the LAD branch coursed at a close distance to the proximal calcified part of the conduit, creating a potential risk of compression in case of expansion. No evidence of coronary compression was seen on angiography or on ECG analysis at this point. To better understand the relationship along the proximal course of the LAD and the conduit, a soft tipped 0.014 inch standard coronary guide wire was advanced into the LAD to a point where it looked to be closest to the conduit (Figures 2A, B). Selective biplane left coronary artery angiography was repeated in a left lateral and a frontal 40° caudal angulation (the so-called “barrel” projection), during inflation of a 20 mm BiB catheter (Figures 2C, D). In the lateral plane the tip of the guidewire projected over the proximal part of the balloon; however, in the barrel view it was clearly leftward from the conduit. This was deemed to be reassuring and the decision was made to implant the percutaneous pulmonary valve (Melody, Medtronic Inc, Minneapolis, MN). After preparing a landing zone with a 34 mm long covered Cheatham Platinum (cCP) stent (NuMed Inc) mounted on a 20 mm BiB catheter, the percutaneous pulmonary valve was implanted on a 20 mm Ensemble delivery system (Melody, Medtronic Inc, Minneapolis, MN). The whole assembly was post-dilated with a 20 mm high-pressure balloon catheter (Mullins, NuMed Inc) before control angiography of the left coronary artery showed unobstructed flow in all branches (Figures 2E, F). Haemodynamic measurements confirmed significant reduction of the RVOT gradient (residual gradient 7 mm Hg) and right ventricle (39/9/12 mm Hg) to systemic pressure (116/71/89 mm Hg) ratio. The patient was discharged home on the second day post intervention.
Figure 2

Step-by-step angiographic images of PPVI. Standard posterior-anterior (PA) (A) and left lateral (LL) (B) projections showing relationship between the narrow conduit (white curved lines), calcifications (black arrows) in the proximal segment of the conduit, and the proximal segment of the left anterior descending (LAD) branch exposed with the aid of the tip of the coronary guidewire (white arrow). Note the hazardous proximity between the proximal part of the LAD branch and the conduit. The LL (C) and the ‘barrel-view’ projection (D) during balloon testing with 20 mm balloon catheter. On LL view, fully inflated balloon seems to project on the tip of the guidewire; however, in the barrel-view projection the tip of the guidewire turns away from the balloon and proximal calcifications. Final selective left coronary angiography in PA (E) and LL (F) projections showing unobstructed flow to all branches

Step-by-step angiographic images of PPVI. Standard posterior-anterior (PA) (A) and left lateral (LL) (B) projections showing relationship between the narrow conduit (white curved lines), calcifications (black arrows) in the proximal segment of the conduit, and the proximal segment of the left anterior descending (LAD) branch exposed with the aid of the tip of the coronary guidewire (white arrow). Note the hazardous proximity between the proximal part of the LAD branch and the conduit. The LL (C) and the ‘barrel-view’ projection (D) during balloon testing with 20 mm balloon catheter. On LL view, fully inflated balloon seems to project on the tip of the guidewire; however, in the barrel-view projection the tip of the guidewire turns away from the balloon and proximal calcifications. Final selective left coronary angiography in PA (E) and LL (F) projections showing unobstructed flow to all branches

Discussion

Despite advances in surgical techniques, RVOT conduits fail over time [1]. Percutaneous pulmonary valve implantation has provided a major step forward in reducing the number of “re-do” surgical conduit replacements during a patient's life [2]. This procedure can be performed with a low morbidity and mortality and excellent medium-term results [3-5]. Along with conduit rupture, coronary compression remains a major potential complication [6-8]. Careful patient selection should include preprocedural imaging (CT and or CMR imaging), with angiographic coronary assessment in selected cases. Balloon interrogation of the conduit with concomitant selective biplane coronary arteriography is invaluable in some cases, but the aggression of the balloon interrogation needs to be balanced by the risk of conduit rupture during this diagnostic step. The PPVI operators should have criteria and protocols for pre-procedure assessment and be prepared to tailor their approach depending on the surgical anatomy. There is no clear method of predicting how a conduit will behave on aggressive expansion and how adjacent structures, including the coronary arteries, will be affected. Opinions vary from expert to expert regarding the “safe distances” between coronary and conduit, the behaviour of soft tissues versus calcified structures, the position of the conduit with respect to the sternum, and how the proposed degree of conduit expansion might predict the amount of excursion of the expanded conduit. All have been touted as determinants of risk of coronary compression [9]. Our approach of combining angiography with the positioning of a coronary wire allows increased information linking the position of the conduit narrowing to the course of the coronary artery. It does not in itself prevent compression but may help predict the likelihood of compression in concerning anatomy. Although major complications during PPVI are rare, we must remember that the risk of surgical conduit replacement in most cases is very low. Our tolerance of risk in these alternative interventional procedures must take this into account in each individual case.
  8 in total

1.  Late follow-up of 1095 patients undergoing operation for complex congenital heart disease utilizing pulmonary ventricle to pulmonary artery conduits.

Authors:  Joseph A Dearani; Gordon K Danielson; Francisco J Puga; Hartzell V Schaff; Carole W Warnes; David J Driscoll; Cathy D Schleck; Duane M Ilstrup
Journal:  Ann Thorac Surg       Date:  2003-02       Impact factor: 4.330

2.  Percutaneous pulmonary valve implantation: two-centre experience with more than 100 patients.

Authors:  Andreas Eicken; Peter Ewert; Alfred Hager; Bjoern Peters; Sohrab Fratz; Titus Kuehne; Raymonde Busch; John Hess; Felix Berger
Journal:  Eur Heart J       Date:  2011-01-27       Impact factor: 29.983

3.  Images in cardiovascular medicine. Transcatheter right ventricular outflow tract intervention: the risk to the coronary circulation.

Authors:  Shankar Sridharan; Louise Coats; Sachin Khambadkone; Andrew M Taylor; Philipp Bonhoeffer
Journal:  Circulation       Date:  2006-06-27       Impact factor: 29.690

4.  The Ross-Konno procedure in children: outcomes, autograft and allograft function, and reoperations.

Authors:  John W Brown; Mark Ruzmetov; Palaniswamy Vijay; Mark D Rodefeld; Mark W Turrentine
Journal:  Ann Thorac Surg       Date:  2006-10       Impact factor: 4.330

5.  Percutaneous insertion of the pulmonary valve.

Authors:  Philipp Bonhoeffer; Younes Boudjemline; Shakeel A Qureshi; Jerome Le Bidois; Laurence Iserin; Philippe Acar; Jacques Merckx; Jean Kachaner; Daniel Sidi
Journal:  J Am Coll Cardiol       Date:  2002-05-15       Impact factor: 24.094

6.  [POL-PAVTI--Polish report on transcatheter pulmonary artery valve implantation of Melody-Medtronic prosthesis in the first 14 patients in Poland].

Authors:  Witold Ruzyłło; Marcin Demkow; Elzbieta K Włodarska; Mirosław Kowalski; Mateusz Spiewak; Hanna Siudalska; Piotr Wolski; Jolanta Miśko; Piotr Hoffman; Jacek Kusa; Małgorzata Szkutnik; Jacek Białkowski; Roland Fiszer; Ewa Urbańska; Lars Sondergaard
Journal:  Kardiol Pol       Date:  2009-10       Impact factor: 3.108

7.  Risk of coronary artery compression among patients referred for transcatheter pulmonary valve implantation: a multicenter experience.

Authors:  Brian H Morray; Doff B McElhinney; John P Cheatham; Evan M Zahn; Darren P Berman; Patrick M Sullivan; James E Lock; Thomas K Jones
Journal:  Circ Cardiovasc Interv       Date:  2013-09-24       Impact factor: 6.546

8.  Percutaneous pulmonary valve implantation: impact of evolving technology and learning curve on clinical outcome.

Authors:  Philipp Lurz; Louise Coats; Sachin Khambadkone; Johannes Nordmeyer; Younes Boudjemline; Silvia Schievano; Vivek Muthurangu; Twin Yen Lee; Giovanni Parenzan; Graham Derrick; Seamus Cullen; Fiona Walker; Victor Tsang; John Deanfield; Andrew M Taylor; Philipp Bonhoeffer
Journal:  Circulation       Date:  2008-04-07       Impact factor: 29.690

  8 in total
  5 in total

1.  Cardiac Magnetic Resonance to Evaluate Percutaneous Pulmonary Valve Implantation in Children and Young Adults.

Authors:  Cesar Gonzalez de Alba; Fernando Molina Berganza; John Brownlee; Muhammad Khan; Dilachew Adebo
Journal:  Tex Heart Inst J       Date:  2018-04-07

2.  Use of a semi-automated cardiac segmentation tool improves reproducibility and speed of segmentation of contaminated right heart magnetic resonance angiography.

Authors:  Animesh Tandon; Nicholas Byrne; Maria de Las Nieves Velasco Forte; Song Zhang; Adrian K Dyer; Jeanne M Dillenbeck; Gerald F Greil; Tarique Hussain
Journal:  Int J Cardiovasc Imaging       Date:  2016-05-12       Impact factor: 2.357

3.  Three-dimensional image fusion guidance of percutaneous pulmonary valve implantation to reduce radiation exposure and contrast dose: A comparison with traditional two-dimensional and three-dimensional rotational angiographic guidance.

Authors:  S Goreczny; T Moszura; P Dryzek; M Lukaszewski; A Krawczuk; J Moll; G J Morgan
Journal:  Neth Heart J       Date:  2017-02       Impact factor: 2.380

Review 4.  Pulmonary Regurgitation- Is the Future Percutaneous or Surgical?

Authors:  Gareth J Morgan
Journal:  Front Pediatr       Date:  2018-07-10       Impact factor: 3.418

5.  Magnetic resonance and computed tomography imaging fusion for live guidance of percutaneous pulmonary valve implantation.

Authors:  Sebastian Góreczny; Paweł Dryżek; Tomasz Moszura; Maciej Łukaszewski; Michał Podgórski; Sarah Nordmeyer; Titus Kuehne; Felix Berger; Stephan Schubert
Journal:  Postepy Kardiol Interwencyjnej       Date:  2018-12-11       Impact factor: 1.426

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.